# EDGAR Filing Document

**Accession Number:** 0000733269
**File Stem:** 0000733269-23-000009
**Filing Date:** 2023-2
**Character Count:** 82810
**Document Hash:** 46c297035034345326f80ddeb3c9b8ac
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000733269-23-000009.hdr.sgml**: 20230207

**ACCESSION NUMBER**: 0000733269-23-000009

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20230207

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230207

**DATE AS OF CHANGE**: 20230207

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LiveRamp Holdings, Inc.
- **CENTRAL INDEX KEY:** 0000733269
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **IRS NUMBER:** 710581897
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38669
- **FILM NUMBER:** 23595157

**BUSINESS ADDRESS:**
- **STREET 1:** 225 BUSH STREET
- **STREET 2:** 17TH FLOOR
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94104
- **BUSINESS PHONE:** 866-352-3267

**MAIL ADDRESS:**
- **STREET 1:** 225 BUSH STREET
- **STREET 2:** 17TH FLOOR
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94104

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Acxiom Holdings, Inc.
- **DATE OF NAME CHANGE:** 20180920

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ACXIOM CORP
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CCX NETWORK INC
- **DATE OF NAME CHANGE:** 19880816

?xml version="1.0" ? ramp-20230207

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

 **Pursuant to Section 13 or 15(d) of** 

**The Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** February 7, 2023

---

| | | |
|:---|:---|:---|
| **LiveRamp Holdings, Inc.** | **LiveRamp Holdings, Inc.** | **LiveRamp Holdings, Inc.** |
| (Exact Name of Registrant as Specified in Its Charter) | (Exact Name of Registrant as Specified in Its Charter) | (Exact Name of Registrant as Specified in Its Charter) |
| **Delaware** | 001-38669 | 83-1269307 |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| 225 Bush Street, Seventeenth Floor<br>San Francisco, CA<br>(Address of Principal Executive Offices) |  | 94104<br>(Zip Code) |
| **(888)** 987-6764<br>(Registrant's Telephone Number, Including Area Code) | **(888)** 987-6764<br>(Registrant's Telephone Number, Including Area Code) | **(888)** 987-6764<br>(Registrant's Telephone Number, Including Area Code) |
| (Former name or former address, if changed since last report) | (Former name or former address, if changed since last report) | (Former name or former address, if changed since last report) |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

| | | |
|:---|:---|:---|
| Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: |
| **Title of each class** | **Trading Symbol** | **Name of each exchange on which registered** |
| Common Stock, $.10 Par Value | RAMP | New York Stock Exchange |

---

---

| | |
|:---|:---|
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). |
| Emerging growth company | ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the |
| Exchange Act. | ☐ |

---

------

**Section 2—Financial Information**

***Item 2.02&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition***

&nbsp;&nbsp;&nbsp;&nbsp;On February 7, 2023, LiveRamp Holdings, Inc. (the "Company") issued a press release announcing the results of its financial performance for its third quarter ended December 31, 2022. The Company will hold a conference call at 1:30 PM PDT today to further discuss this information. Interested parties are invited to listen to the webcast, which will be broadcast via the Internet at www.liveramp.com. The press release is furnished herewith as Exhibit 99.1 and incorporated by reference herein.

**Section 9—Financial Statements and Exhibits**

***Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits***

**(d)&nbsp;&nbsp;&nbsp;&nbsp;Exhibits**

---

| | |
|:---|:---|
| Exhibit Number | Description |
| 99.1 | <u>[Press Release of the Company dated February 7, 2023](a2023q3pressreleaseprfinsex.htm)</u> |
| 101.sch | Inline XBRL Taxonomy Extension Schema Document |
| 101.lab | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.pre | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data file (formatted as Inline XBRL and contained in Exhibit 101) |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: February 7, 2023

---

| | |
|:---|:---|
| LiveRamp Holdings, Inc. | LiveRamp Holdings, Inc. |
| By: | /s/ Jerry C. Jones |
| Name: | Jerry C. Jones |
| Title: | Chief Ethics and Legal Officer & Executive Vice President |

---

## Exhibit 99.1

**LIVERAMP ANNOUNCES THIRD QUARTER RESULTS**

**Total Revenue up 13% year over year and Subscription Revenue up 14%**

**$16 million in Operating Cash Flow**

**$150 million of Stock Repurchased Fiscal Year to Date**

**Share Repurchase Authorization Extended and Expanded**

**SAN FRANCISCO, Calif., February 7, 2023**—LiveRamp<sup>®</sup> (NYSE: RAMP), the leading data collaboration platform, today announced its financial results for the quarter ended December 31, 2022.

**Q3 Financial Highlights**<sup>1</sup>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total revenue was $159 million, up 13%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Subscription revenue was $126 million, up 14%, and accounted for 80% of total revenue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Marketplace & Other revenue was $32 million, up 9%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP gross profit was $115 million, up 13%. GAAP gross margin of 73% was unchanged. Non-GAAP gross profit was $121 million, up 12%. Non-GAAP gross margin of 76% contracted by 1 percentage point.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP operating loss was $24 million compared to $14 million. Non-GAAP operating income was $26 million compared to $15 million. Non-GAAP operating margin of 16% expanded by 6 percentage points.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP loss per share was $0.46 and non-GAAP earnings per share were $0.28.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net cash provided by operating activities was $16 million compared to $25 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In the quarter, the Company repurchased approximately 2.3 million shares for $50 million under its share repurchase program. Fiscal year to date, the Company has repurchased approximately 6.1 million shares for $150 million. Since inception of the program in August 2011, the Company has returned approximately $1.4 billion in capital to shareholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On December 20, 2022 the Company's Board of Directors approved an extension of the share repurchase program by two years to December 31, 2024 and a $100 million increase in the authorization. There is currently $218 million available under the authorization.

A reconciliation between GAAP and non-GAAP results is provided in the schedules to this press release.

"We continue winning with the world's largest brand marketers, reinforcing that we are essential infrastructure for the advertising ecosystem," said LiveRamp CEO Scott Howe. "Our identity and collaboration products, with connections to over 2,000 publishers, uniquely support all of their marketing activities."

"We delivered solid third quarter results, with top-line growth and strong free cash flow," added President and CFO Warren Jenson. "Looking to FY24, we expect to deliver another year of strong operating profit growth and to return a substantial portion of free cash flow to shareowners through share repurchases."

<sup>1</sup> Unless otherwise indicated, all comparisons are to the prior year period.

P 1

------

**GAAP and Non-GAAP Results**

The following table summarizes the Company's financial results for its third fiscal quarter ($ in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Q3 Fiscal 2023** | **Q3 Fiscal 2023** | **Q3 Fiscal 2022** | **Q3 Fiscal 2022** |
| | **Results** | **Results** | **Results** | **Results** |
| | GAAP | Non-GAAP | GAAP | Non-GAAP |
| *Subscription revenue* | $126 |  | $111 |  |
| *YoY change %* | 14% |  | 19% |  |
| *Marketplace & other revenue* | $32 |  | $29 |  |
| *YoY change %* | 9% |  | 12% |  |
| *Total revenue* | $159 |  | $141 |  |
| *YoY change %* | 13% |  | 17% |  |
| *Gross profit* | $115 | $121 | $102 | $108 |
| *% Gross margin* | 73% | 76% | 73% | 77% |
| *YoY change, pts* | 0pts | (1)pts | 4pts | 3pts |
| *Operating income (loss)* | $(24) | $26 | $(14) | $15 |
| *% Operating margin* | (15)% | 16% | (10)% | 10% |
| *YoY change, pts* | (5)pts | 6pts | 3pts | 0pts |
| *Net earnings (loss)* | $(30) | $19 | $(15) | $10 |
| *Earnings (loss) per share* | $(0.46) | $0.28 | $(0.23) | $0.14 |
| *Shares to Calculate EPS* | 64.8 | 65.4 | 68.2 | 69.9 |
| *YoY change %* | (5)% | (7)% | 3% | 0% |
| *Net operating cash flow* | $16 |  | $25 |  |
| *Free cash flow to equity* |  | $16 |  | $24 |
| *Totals may not sum due to rounding.* | *Totals may not sum due to rounding.* | *Totals may not sum due to rounding.* | *Totals may not sum due to rounding.* | *Totals may not sum due to rounding.* |

---

A detailed discussion of our non-GAAP financial measures and a reconciliation between GAAP and non-GAAP results is provided in the schedules to this press release.

P 2

------

**Additional Business Highlights & Metrics**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company's Authenticated Traffic Solution (ATS) has reached global scale. There are currently more than 160 supply-side platforms (SSPs) and demand-side platforms (DSPs) live or committed to bid on RampID™ and ATS, including The Trade Desk, Xandr, Amobee, Criteo, Roku Oneview, and MediaMath. Further, in March 2022, LiveRamp announced an expanded partnership with The Trade Desk to power European Unified ID (EUID) via its ATS infrastructure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• To date, over 2,000 publishers, representing more than 12,000 deployed domains, have integrated ATS worldwide, including Amazon Publisher Services, Microsoft, Hearst, CafeMedia, Leaf Group, Prisma Media and Burda.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• At its November 2022 re:Invent conference, Amazon Web Services (AWS) named LiveRamp as a key industry partner for its new Marketing and Advertising Initiative and forthcoming AWS Clean Rooms service launch. LiveRamp published its new embedded identity resolution solutions in the AWS Marketplace in December 2022 ahead of the AWS Clean Rooms release in January 2023. Support for AWS Clean Rooms gives customers a collaborative approach to more effective media measurement and planning. As part of LiveRamp's continued work with AWS, this latest integration reinforces our commitment to help clients improve their customer intelligence through accurate and secure data collaboration in cloud environments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Recently, LiveRamp and Pinterest announced a new partnership to pilot clean rooms for select advertising partners using LiveRamp's data collaboration technology, Safe Haven. Grocery retailer Albertsons will be the first advertiser to use the new solution to support its retail media network. LiveRamp's Safe Haven platform provides a protected environment where brands can join select first-party data with Pinterest platform data without having to share or reveal customers' personal identifiable information. This data sharing will enable enhanced measurement of advertising campaigns, such as closed-loop attribution, without compromising data protection.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• LiveRamp has 910 direct subscription customers, up from 890 in the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• LiveRamp has 94 customers whose subscription contracts exceed $1 million in annual revenue, up from 86 in the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• During the third quarter, subscription net retention was 101% and platform net retention was 102%.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current remaining performance obligations (CRPO), which is contracted and committed revenue expected to be recognized over the next 12 months, was $324 million, up 12% compared to the prior year period.

P 3

------

**Financial Outlook** 

LiveRamp's non-GAAP operating income guidance excludes the impact of non-cash stock compensation, purchased intangible asset amortization, and restructuring and related charges.

For the fourth quarter of fiscal 2023, LiveRamp expects to report:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue of between $147 million and $152 million, an increase of between 4% and 7% year-over-year

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP operating loss of between $26 million and $23 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP operating income of between $13 million and $16 million

For fiscal 2023, LiveRamp updates its guidance and expects to report:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue of between $595 million and $600 million, an increase of approximately 13% year-over-year

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• GAAP operating loss of between $105 million and $102 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Non-GAAP operating income of between $60 million and $63 million

**Conference Call**

LiveRamp will hold a conference call at 1:30 p.m. PT today to further discuss this information. Interested parties are invited to listen to the call which will be broadcast via the Internet and can be found on LiveRamp's investor site. A slide presentation will be referenced during the call and can be accessed here.

**About LiveRamp**

LiveRamp is the data collaboration platform trusted by forward-looking global companies to connect customer data from anywhere to everywhere. The category-defining pioneer with decades of expertise in online-offline identity resolution, LiveRamp is setting the new standard for a 360° customer view in the modern data stack through secure, privacy-first collaboration within companies, across companies, and between companies and their media and marketing partners to personalize and improve the customer journey. For more information, visit www.liveramp.com.

**Forward-Looking Statements** 

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended (the "PSLRA"). These statements, which are not statements of historical fact, may contain estimates, assumptions, projections and/or expectations regarding the Company's financial position, results of operations for fiscal 2023, fiscal 2024 and beyond, market position, product development, growth opportunities, economic conditions, and other similar forecasts and statements of expectation. Forward-looking statements are often identified by words or phrases such as "anticipate," "estimate," "plan," "expect," "believe," "intend," "foresee," or the negative of these terms or other similar variations thereof.

These forward-looking statements are not guarantees of future performance and are subject to a number of factors and uncertainties that could cause the Company's actual results and experiences to differ materially from the anticipated results and expectations expressed in the forward-looking statements.

Among the factors that may cause actual results and expectations to differ from anticipated results and expectations expressed in forward-looking statements are uncertainties related to the ongoing COVID-19 pandemic, rising interest rates, cost increases and general inflationary pressure and the associated

P 4

------

impacts on our suppliers, customers and partners; the Company's dependence upon customer renewals; new customer additions and upsell within our subscription business; our reliance upon partners, including data suppliers; competition; and attracting and retaining talent. Additional risks include maintaining our culture and our ability to innovate and evolve while operating in a hybrid work environment, with some employees working remotely at least some of the time within a rapidly changing industry, while also avoiding disruption from reductions in our current workforce as well as disruptions resulting from acquisition and divestiture activities. Our international operations are also subject to risks, including war and civil unrest, that may harm the Company's business. The risk of a significant breach of the confidentiality of the information or the security of our or our customers', suppliers', or other partners' computer systems, or the risk that our current insurance coverage may not be adequate for such a breach, that an insurer might deny coverage for a claim or that such insurance will continue to be available to us on commercially reasonable terms, or at all, could be detrimental to our business, reputation and results of operations. Other business risks include unfavorable publicity and negative public perception about our industry; interruptions or delays in service from data center hosting vendors we rely upon; and our dependence on the continued availability of third-party data hosting and transmission services. Our clients' ability to use data on our platform could be restricted if the industry's use of third-party cookies and tracking technology declines due to technology platform changes, regulation or increased user controls. Changes in regulations relating to information collection and use represents a risk, as well as changes in tax laws and regulations that are applied to our customers which could cause enterprise software budget tightening. In addition, third parties may claim that we are infringing their intellectual property or may infringe our intellectual property which could result in competitive injury and / or the incurrence of significant costs and draining of our resources.

For a discussion of these and other risks and uncertainties, please refer to LiveRamp's Annual Report on Form 10-K for our fiscal year 2022 ended March 31, 2022, and LiveRamp's Quarterly Reports on Form 10-Q issued in fiscal year 2023.

The financial information set forth in this press release reflects estimates based on information available at this time.

LiveRamp assumes no obligation and does not currently intend to update these forward-looking statements.

To automatically receive LiveRamp financial news by email, please visit www.LiveRamp.com and subscribe to email alerts.

**For more information, contact:** 

LiveRamp Investor Relations

Investor.Relations@LiveRamp.com

ERAMP

LiveRampⓇ, RampIDTM, AbilitecⓇ, Safe HavenⓇ and all other LiveRamp marks contained herein are trademarks or service marks of LiveRamp, Inc. All other marks are the property of their respective owners.

P 5

------

---

| | | | |
|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) |
|  | For the three months ended December 31, | For the three months ended December 31, | For the three months ended December 31, |
|  |  |  | $% |
|  | 2022 | 2021 | Variance |
| Revenues | $158615 | $140604 | 12.8% |
| Cost of revenue | 43287 | 38557 | 12.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 115328 | 102047 | 13.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;***% Gross margin*** | ***72.7*** *%*** | ***72.6*** *%*** |  |
| Operating expenses: |  |  |  |
| &nbsp;&nbsp;Research and development | 43175 | 41870 | 3.1% |
| &nbsp;&nbsp;Sales and marketing | 47702 | 46324 | 3.0% |
| &nbsp;&nbsp;General and administrative | 36657 | 27639 | 32.6% |
| &nbsp;&nbsp;Gains, losses and other items, net | 11743 |  | NA |
| Total operating expenses | 139277 | 115833 | 20.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from operations | (23949) | (13786) | (73.7)% |
| &nbsp;&nbsp;&nbsp;&nbsp;***% Margin*** | ***(15.1)*** *%*** | ***(9.8)*** *%*** |  |
| Total other expense, net | (736) | (241) | (205.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from continuing operations before income taxes | (24685) | (14027) | (76.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | 5835 | 1348 | 332.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss from continuing operations | (30520) | (15375) | (98.5)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings from discontinued operations, net of tax | 836 |  | n/a |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(29684) | $(15375) | (93.1)% |
| Basic earnings (loss) per share |  |  |  |
| &nbsp;&nbsp;Continuing operations | $(0.47) | $(0.23) | (108.9)% |
| &nbsp;&nbsp;Discontinued operations | 0.01 |  | n/a |
| Basic loss per share | $(0.46) | $(0.23) | (103.2)% |
| Diluted earnings (loss) per share |  |  |  |
| &nbsp;&nbsp;Continuing operations | $(0.47) | $(0.23) | (108.9)% |
| &nbsp;&nbsp;Discontinued operations | 0.01 |  | n/a |
| Diluted loss per share | $(0.46) | $(0.23) | (103.2)% |
| Basic weighted average shares | 64784 | 68190 |  |
| Diluted weighted average shares | 64784 | 68190 |  |

---

*Totals may not sum due to rounding*.

P 6

------

---

| | | | |
|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| CONSOLIDATED STATEMENTS OF OPERATIONS | CONSOLIDATED STATEMENTS OF OPERATIONS | CONSOLIDATED STATEMENTS OF OPERATIONS | CONSOLIDATED STATEMENTS OF OPERATIONS |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) |
|  | For the nine months ended December 31, | For the nine months ended December 31, | For the nine months ended December 31, |
|  |  |  | $% |
|  | 2022 | 2021 | Variance |
| Revenues | $447957 | $386932 | 15.8% |
| Cost of revenue | 126612 | 107951 | 17.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 321345 | 278981 | 15.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;***% Gross margin*** | ***71.7*** *%*** | ***72.1*** *%*** |  |
| Operating expenses: |  |  |  |
| &nbsp;&nbsp;Research and development | 136975 | 112434 | 21.8% |
| &nbsp;&nbsp;Sales and marketing | 144931 | 127812 | 13.4% |
| &nbsp;&nbsp;General and administrative | 92519 | 75008 | 23.3% |
| &nbsp;&nbsp;Gains, losses and other items, net | 25593 | 1296 | 1874.8% |
| Total operating expenses | 400018 | 316550 | 26.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from operations | (78673) | (37569) | (109.4)% |
| &nbsp;&nbsp;&nbsp;&nbsp;***% Margin*** | ***(17.6)*** *%*** | ***(9.7)*** *%*** |  |
| Total other income, net | 2211 | 30510 | (92.8)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from continuing operations before income taxes | (76462) | (7059) | (983.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense (benefit) | 11712 | (2618) | 547.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss from continuing operations | (88174) | (4441) | (1885.5)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings from discontinued operations, net of tax | 836 |  | n/a |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(87338) | $(4441) | (1866.6)% |
| Basic earnings (loss) per share |  |  |  |
| &nbsp;&nbsp;Continuing operations | $(1.32) | $(0.07) | (1927.9)% |
| &nbsp;&nbsp;Discontinued operations | 0.01 |  | n/a |
| Basic loss per share | $(1.31) | $(0.07) | (1908.6)% |
| Diluted earnings (loss) per share |  |  |  |
| &nbsp;&nbsp;Continuing operations | $(1.32) | $(0.07) | (1927.9)% |
| &nbsp;&nbsp;Discontinued operations | 0.01 |  | n/a |
| Diluted loss per share | $(1.31) | $(0.07) | (1908.6)% |
| Basic weighted average shares | 66761 | 68187 |  |
| Diluted weighted average shares | 66761 | 68187 |  |

---

*Totals may not sum due to rounding.*

P 7

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| <u>RECONCILIATION OF GAAP TO NON-GAAP EPS (1)</u> | <u>RECONCILIATION OF GAAP TO NON-GAAP EPS (1)</u> | <u>RECONCILIATION OF GAAP TO NON-GAAP EPS (1)</u> | <u>RECONCILIATION OF GAAP TO NON-GAAP EPS (1)</u> | <u>RECONCILIATION OF GAAP TO NON-GAAP EPS (1)</u> |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) |
|  | For the three months ended December 31, | For the three months ended December 31, | For the nine months ended December 31, | For the nine months ended December 31, |
|  | 2022 | 2021 | 2022 | 2021 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from continuing operations before income taxes | $(24685) | $(14027) | $(76462) | $(7059) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense (benefit) | 5835 | 1348 | 11712 | (2618) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss from continuing operations | (30520) | (15375) | (88174) | (4441) |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings from discontinued operations, net of tax | 836 |  | 836 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(29684) | $(15375) | $(87338) | $(4441) |
| Loss per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.46) | $(0.23) | $(1.31) | $(0.07) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.46) | $(0.23) | $(1.31) | $(0.07) |
| Excluded items: |  |  |  |  |
| &nbsp;&nbsp;Purchased intangible asset amortization (cost of revenue) | $4209 | $4647 | $13489 | $13904 |
| &nbsp;&nbsp;Non-cash stock compensation (cost of revenue and operating expenses) | 29624 | 23758 | 81142 | 61475 |
| &nbsp;&nbsp;Transformation costs (general and administrative) | 4112 |  | 5362 |  |
| &nbsp;&nbsp;Restructuring and merger charges (gains, losses, and other) | 11743 |  | 25593 | 1296 |
| &nbsp;&nbsp;Gain on retained profits interest (other income) |  | (183) |  | (30235) |
| Total excluded items, continuing operations | 49688 | 28222 | 125586 | 46440 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations before income taxes and excluding items | 25003 | 14195 | 49124 | 39381 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense (2) | 6468 | 4271 | 12262 | 5124 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net earnings from continuing operations | $18535 | $9924 | $36862 | $34257 |
| Non-GAAP earnings per share from continuing operations: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.29 | $0.15 | $0.55 | $0.50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.28 | $0.14 | $0.55 | $0.49 |
| Basic weighted average shares | 64784 | 68190 | 66761 | 68187 |
| Diluted weighted average shares | 65356 | 69938 | 67373 | 69626 |

---

(1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A.

(2) Income taxes were calculated by applying the estimated annual effective tax rate to year-to-date pretax income or loss and adjusting for discrete tax items in the period. The differences between our GAAP and non-GAAP effective tax rates were primarily due to the net tax effects of the excluded items, coupled with larger pre-tax losses for GAAP purposes versus smaller pre-tax losses or income for non-GAAP purposes.

P 8

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| <u>RECONCILIATION OF GAAP TO NON-GAAP INCOME (LOSS) FROM OPERATIONS (1)</u> | <u>RECONCILIATION OF GAAP TO NON-GAAP INCOME (LOSS) FROM OPERATIONS (1)</u> | <u>RECONCILIATION OF GAAP TO NON-GAAP INCOME (LOSS) FROM OPERATIONS (1)</u> | <u>RECONCILIATION OF GAAP TO NON-GAAP INCOME (LOSS) FROM OPERATIONS (1)</u> | <u>RECONCILIATION OF GAAP TO NON-GAAP INCOME (LOSS) FROM OPERATIONS (1)</u> |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  | For the three months ended December 31, | For the three months ended December 31, | For the nine months ended December 31, | For the nine months ended December 31, |
|  | 2022 | 2021 | 2022 | 2021 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from continuing operations | $(23949) | $(13786) | $(78673) | $(37569) |
| Excluded items: |  |  |  |  |
| &nbsp;&nbsp;Purchased intangible asset amortization (cost of revenue) | 4209 | 4647 | 13489 | 13904 |
| &nbsp;&nbsp;Non-cash stock compensation (cost of revenue and operating expenses) | 29624 | 23758 | 81142 | 61475 |
| &nbsp;&nbsp;Restructuring and merger charges (gains, losses, and other) | 11743 |  | 25593 | 1296 |
| &nbsp;&nbsp;Transformation costs (general and administrative) | 4112 |  | 5362 |  |
| Total excluded items | 49688 | 28405 | 125586 | 76675 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations before excluded items | $25739 | $14619 | $46913 | $39106 |

---

(1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

P 9

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| RECONCILIATION OF ADJUSTED EBITDA (1) | RECONCILIATION OF ADJUSTED EBITDA (1) | RECONCILIATION OF ADJUSTED EBITDA (1) | RECONCILIATION OF ADJUSTED EBITDA (1) | RECONCILIATION OF ADJUSTED EBITDA (1) |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  | For the three months ended December 31, | For the three months ended December 31, | For the nine months ended December 31, | For the nine months ended December 31, |
|  | 2022 | 2021 | 2022 | 2021 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss from continuing operations | $(30520) | $(15375) | $(88174) | $(4441) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense (benefit) | 5835 | 1348 | 11712 | (2618) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense (income) | 736 | 241 | (2211) | (30510) |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from operations | (23949) | (13786) | (78673) | (37569) |
| Depreciation and amortization | 5131 | 5827 | 16561 | 18231 |
| EBITDA | $(18818) | $(7959) | $(62112) | $(19338) |
| Other adjustments: |  |  |  |  |
| &nbsp;&nbsp;Non-cash stock compensation (cost of revenue and operating expenses) | $29624 | $23758 | $81142 | $61475 |
| &nbsp;&nbsp;Restructuring and merger charges (gains, losses, and other) | 11743 |  | 25593 | 1296 |
| &nbsp;&nbsp;Transformation costs (general and administrative) | 4112 |  | 5362 |  |
| &nbsp;&nbsp;Other adjustments | 45479 | 23758 | 112097 | 62771 |
| Adjusted EBITDA | $26661 | $15799 | $49985 | $43433 |

---

(1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures, the usefulness of these measures and the material limitations on the usefulness of these measures, please see Appendix A.

P 10

------

---

| | | | |
|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| CONDENSED CONSOLIDATED BALANCE SHEETS | CONDENSED CONSOLIDATED BALANCE SHEETS | CONDENSED CONSOLIDATED BALANCE SHEETS | CONDENSED CONSOLIDATED BALANCE SHEETS |
| (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  | December 31, | March 31, | $% |
|  | 2022 | 2022 | Variance |
| Assets |  |  |  |
| Current assets: |  |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $453516 | $600162 | (24.4)% |
| &nbsp;&nbsp;Trade accounts receivable, net | 173409 | 148343 | 16.9% |
| &nbsp;&nbsp;Refundable income taxes, net | 27097 | 30354 | (10.7)% |
| &nbsp;&nbsp;Other current assets | 42172 | 36975 | 14.1% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 696194 | 815834 | (14.7)% |
| Property and equipment | 42954 | 45001 | (4.5)% |
| &nbsp;&nbsp;Less - accumulated depreciation and amortization | 34145 | 33470 | 2.0% |
| Property and equipment, net | 8809 | 11531 | (23.6)% |
| Intangible assets, net | 13203 | 26718 | (50.6)% |
| Goodwill | 363129 | 363845 | (0.2)% |
| Deferred commissions, net | 32717 | 30594 | 6.9% |
| Other assets, net | 52431 | 85214 | (38.5)% |
|  | $1166483 | $1333736 | (12.5)% |
| Liabilities and Stockholders' Equity |  |  |  |
| Current liabilities: |  |  |  |
| &nbsp;&nbsp;Trade accounts payable | $83938 | $83197 | 0.9% |
| &nbsp;&nbsp;Accrued payroll and related expenses | 33250 | 39188 | (15.2)% |
| &nbsp;&nbsp;Other accrued expenses | 42394 | 46067 | (8.0)% |
| &nbsp;&nbsp;Deferred revenue | 16195 | 16114 | 0.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 175777 | 184566 | (4.8)% |
| Other liabilities | 79097 | 86110 | (8.1)% |
| &nbsp;&nbsp;Stockholders' equity: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock |  |  | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock | 15205 | 14984 | 1.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 1810383 | 1721118 | 5.2% |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 1333655 | 1420993 | (6.1)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | 4182 | 5730 | (27.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, at cost | (2251816) | (2099765) | 7.2% |
| Total stockholders' equity | 911609 | 1063060 | (14.2)% |
|  | $1166483 | $1333736 | (12.5)% |

---

P 11

------

---

| | | |
|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
| (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  | For the three months ended December 31, | For the three months ended December 31, |
|  | 2022 | 2021 |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;Net loss | $(29684) | $(15375) |
| &nbsp;&nbsp;Earnings from discontinued operations | (836) |  |
| &nbsp;&nbsp;Non-cash operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 5131 | 5827 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal or impairment of assets | 4124 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Lease impairments | 5940 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for doubtful accounts | 613 | 1845 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (14) | 315 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash stock compensation expense | 29624 | 23758 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | (15722) | (27803) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred commissions | (1203) | (1495) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | (7372) | (1331) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities | 20168 | 34358 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes, net | 5454 | 1630 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | (453) | 3927 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 15770 | 25473 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (179) | (1316) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sales of assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of strategic investment |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid in acquisitions, net of cash received |  | (2008) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution from retained profits interest |  | 184 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of investments | (3000) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from investments | 3000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of strategic investments | (500) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (679) | (3140) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds related to the issuance of common stock under stock and employee benefit plans | 1664 | 1905 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares repurchased for tax withholdings upon vesting of stock-based awards | (764) | (1674) |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition of treasury stock | (49906) | (5147) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (49006) | (4916) |

---

P 12

------

---

| | | |
|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
| (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  | For the three months ended December 31, | For the three months ended December 31, |
|  | 2022 | 2021 |
| Cash flows from discontinued operations: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;From operating activities | 836 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by discontinued operations | 836 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect of exchange rate changes on cash | 993 | (48) |
| Net change in cash and cash equivalents | (32086) | 17369 |
| Cash and cash equivalents at beginning of period | 485602 | 544321 |
| Cash and cash equivalents at end of period | $453516 | $561690 |
| **Supplemental cash flow information:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid (received) for income taxes, net | $(751) | $(246) |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease assets obtained in exchange for operating lease liabilities | $— | $17211 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment remaining unpaid at period end | $77 | $353 |

---

P 13

------

---

| | | |
|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
| (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  | For the nine months ended December 31, | For the nine months ended December 31, |
|  | 2022 | 2021 |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;Net loss | $(87338) | $(4441) |
| &nbsp;&nbsp;Earnings from discontinued operations | (836) |  |
| &nbsp;&nbsp;Non-cash operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 16561 | 18231 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on disposal or impairment of assets | 4121 | 142 |
| &nbsp;&nbsp;&nbsp;&nbsp;Lease impairments | 18165 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of strategic investments | (194) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on distribution from retained profits interest |  | (30235) |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for doubtful accounts | 1728 | 3127 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 204 | (456) |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash stock compensation expense | 81142 | 61475 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | (27171) | (45876) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred commissions | (2123) | (6864) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 1588 | 22077 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and other liabilities | (9309) | (2471) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes, net | 6967 | 998 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 271 | 3426 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 3776 | 19133 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (4593) | (2619) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of strategic investment | 400 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid in acquisitions, net of cash received |  | (10376) |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution from retained profits interest |  | 31184 |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of investments | (3000) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from investments | 3000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchases of strategic investments | (500) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) investing activities | (4693) | 18189 |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds related to the issuance of common stock under stock and employee benefit plans | 6255 | 6183 |
| &nbsp;&nbsp;&nbsp;&nbsp;Shares repurchased for tax withholdings upon vesting of stock-based awards | (2054) | (14216) |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition of treasury stock | (149997) | (49224) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | (145796) | (57257) |

---

P 14

------

---

| | | |
|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
| (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  | For the nine months ended December 31, | For the nine months ended December 31, |
|  | 2022 | 2021 |
| Cash flows from discontinued operations: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;From operating activities | 836 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by discontinued operations | 836 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect of exchange rate changes on cash | (769) | (62) |
| Net change in cash and cash equivalents | (146646) | (19997) |
| Cash and cash equivalents at beginning of period | 600162 | 581687 |
| Cash and cash equivalents at end of period | $453516 | $561690 |
| **Supplemental cash flow information:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid (received) for income taxes, net | $3418 | $(2815) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease assets obtained in exchange for operating lease liabilities | $— | $52902 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment remaining unpaid at period end | $77 | $353 |

---

P 15

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC AND SUBSIDIARIES |
| CALCULATION OF FREE CASH FLOW TO EQUITY (1) | CALCULATION OF FREE CASH FLOW TO EQUITY (1) | CALCULATION OF FREE CASH FLOW TO EQUITY (1) | CALCULATION OF FREE CASH FLOW TO EQUITY (1) | CALCULATION OF FREE CASH FLOW TO EQUITY (1) | CALCULATION OF FREE CASH FLOW TO EQUITY (1) | CALCULATION OF FREE CASH FLOW TO EQUITY (1) | CALCULATION OF FREE CASH FLOW TO EQUITY (1) | CALCULATION OF FREE CASH FLOW TO EQUITY (1) | CALCULATION OF FREE CASH FLOW TO EQUITY (1) |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  | 6/30/2021 | 9/30/2021 | 12/31/2021 | 3/31/2022 | FY2022 | 6/30/2022 | 9/30/2022 | 12/31/2022 | FY2023 |
| Net Cash Provided by (Used in) Operating Activities | $(17241) | $10901 | $25473 | $58944 | $78077 | $(33369) | $21375 | $15770 | $3776 |
| Less: |  |  |  |  |  |  |  |  |  |
| Capital expenditures | (427) | (876) | (1316) | (1880) | (4499) | (1741) | (2673) | (179) | (4593) |
| Free Cash Flow to Equity | $(17668) | $10025 | $24157 | $57064 | $73578 | $(35110) | $18702 | $15591 | $(817) |

---

(1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A.

P 16

------

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) |
|  |  |  |  |  |  |  |  |  |  | FY23 to FY22 | FY23 to FY22 |
|  | 6/30/2021 | 9/30/2021 | 12/31/2021 | 3/31/2022 | FY2022 | 6/30/2022 | 9/30/2022 | 12/31/2022 | FY2023 | % | $ |
| Revenues | $119038 | $127290 | $140604 | $141725 | $528657 | $142243 | $147099 | $158615 | $447957 | 12.8% | $18011 |
| Cost of revenue | 34315 | 35079 | 38557 | 39476 | 147427 | 41021 | 42304 | 43287 | 126612 | 12.3% | 4730 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 84723 | 92211 | 102047 | 102249 | 381230 | 101222 | 104795 | 115328 | 321345 | 13.0% | 13281 |
| &nbsp;&nbsp;&nbsp;&nbsp;***% Gross margin*** | ***71.2*** *%*** | ***72.4*** *%*** | ***72.6*** *%*** | ***72.1*** *%*** | ***72.1*** *%*** | ***71.2*** *%*** | ***71.2*** *%*** | ***72.7*** *%*** | ***71.7*** *%*** |  |  |
| Operating expenses |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 34776 | 35788 | 41870 | 45501 | 157935 | 47661 | 46139 | 43175 | 136975 | 3.1% | 1305 |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales and marketing | 41979 | 39509 | 46324 | 54951 | 182763 | 51280 | 45949 | 47702 | 144931 | 3.0% | 1378 |
| &nbsp;&nbsp;&nbsp;&nbsp;General and administrative | 24291 | 23078 | 27639 | 29583 | 104591 | 27144 | 28718 | 36657 | 92519 | 32.6% | 9018 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gains, losses and other items, net | 1278 | 18 |  | 183 | 1479 | 739 | 13111 | 11743 | 25593 | NA | 11743 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 102324 | 98393 | 115833 | 130218 | 446768 | 126824 | 133917 | 139277 | 400018 | 20.2% | 23444 |
| Loss from operations | (17601) | (6182) | (13786) | (27969) | (65538) | (25602) | (29122) | (23949) | (78673) | (73.7)% | (10163) |
| % Margin | **(14.8)%** | **(4.9)%** | **(9.8)%** | **(19.7)%** | **(12.4)%** | **(18.0)%** | **(19.8)%** | **(15.1)%** | **(17.6)%** |  |  |
| Total other income (expense), net | 30601 | 150 | (241) | (47) | 30463 | 699 | 2248 | (736) | 2211 | (205.4)% | (495) |
| Loss before income taxes | 13000 | (6032) | (14027) | (28016) | (35075) | (24903) | (26874) | (24685) | (76462) | (76.0)% | (10658) |
| Income taxes expense (benefit) | (4365) | 399 | 1348 | 1376 | (1242) | 2315 | 3562 | 5835 | 11712 | 332.9% | 4487 |
| Net loss from continuing operations | 17365 | (6431) | (15375) | (29392) | (33833) | (27218) | (30436) | (30520) | (88174) | (98.5)% | $(15145) |
| Earnings from discontinued operations, net of tax |  |  |  |  |  |  |  | 836 | 836 | —% | $836 |
| Net earnings (loss) | $17365 | $(6431) | $(15375) | $(29392) | $(33833) | $(27218) | $(30436) | $(29684) | $(87338) | (93.1)% | $(14309) |
| Diluted earnings (loss) per share | $0.25 | $(0.09) | $(0.23) | $(0.43) | $(0.50) | $(0.40) | (0.45) | (0.46) | (1.31) | (103.2)% | $(0.23) |
| Some earnings (loss) per share amounts may not add due to rounding. | Some earnings (loss) per share amounts may not add due to rounding. | Some earnings (loss) per share amounts may not add due to rounding. | Some earnings (loss) per share amounts may not add due to rounding. |  |  |  |  |  |  |  |  |

---

P 17

------

P 18

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) |
|  | 6/30/2021 | 9/30/2021 | 12/31/2021 | 3/31/2022 | FY2022 | 6/30/2022 | 9/30/2022 | 12/31/2022 | FY2023 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before income taxes | $13000 | $(6032) | $(14027) | $(28016) | $(35075) | $(24903) | (26874) | (24685) | (76462) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes (benefit) | (4365) | 399 | 1348 | 1376 | (1242) | 2315 | 3562 | 5835 | 11712 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net earnings (loss) | 17365 | (6431) | (15375) | (29392) | (33833) | (27218) | (30436) | (30520) | (88174) |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings from discontinued operations, net of tax |  |  |  |  |  |  |  | 836 | 836 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net earnings (loss) | 17365 | (6431) | (15375) | (29392) | (33833) | (27218) | (30436) | (29684) | (87338) |
| Earnings (loss) per share: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.25 | $(0.09) | $(0.23) | $(0.43) | $(0.50) | $(0.40) | (0.45) | (0.46) | (1.31) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.25 | $(0.09) | $(0.23) | $(0.43) | $(0.50) | $(0.40) | (0.45) | (0.46) | (1.31) |
| Excluded items: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Purchased intangible asset amortization (cost of revenue) | 4645 | 4612 | 4647 | 4807 | 18711 | 4643 | 4637 | 4209 | 13489 |
| &nbsp;&nbsp;&nbsp;Non-cash stock compensation (cost of revenue and operating expenses) | 18496 | 19221 | 23758 | 25782 | 87257 | 24225 | 27293 | 29624 | 81142 |
| &nbsp;&nbsp;&nbsp;Restructuring and merger charges (gains, losses, and other) | 1278 | 18 |  | 183 | 1479 | 739 | 13111 | 11743 | 25593 |
| &nbsp;&nbsp;&nbsp;Transformation costs (general and administrative) |  |  |  |  |  |  | 1250 | 4112 | 5362 |
| &nbsp;&nbsp;&nbsp;Gain on retained profits interest (other income) | (30052) |  | (183) |  | (30235) |  |  |  |  |
| Total excluded items | $(5633) | $23851 | $28222 | $30772 | $77212 | $29607 | $46291 | $49688 | $125586 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes and excluding items | $7367 | $17819 | $14195 | $2756 | $42137 | $4704 | $19417 | $25003 | $49124 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes expense (benefit) | 865 | (12) | 4271 | 3391 | 8515 | 1237 | 4557 | 6468 | 12262 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net earnings (loss) | $6502 | $17831 | $9924 | $(635) | $33622 | $3467 | $14860 | $18535 | $36862 |

---

P 19

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) | RECONCILIATION OF GAAP TO NON-GAAP EPS (1) |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) | (Dollars in thousands, except per share amounts) |
|  | 6/30/2021 | 9/30/2021 | 12/31/2021 | 3/31/2022 | FY2022 | 6/30/2022 | 9/30/2022 | 12/31/2022 | FY2023 |
| Non-GAAP earnings (loss) per share: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.10 | $0.26 | $0.15 | $(0.01) | $0.49 | $0.05 | $0.22 | $0.29 | $0.55 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.09 | $0.26 | $0.14 | $(0.01) | $0.48 | $0.05 | $0.22 | $0.28 | $0.55 |
| Basic weighted average shares | 68328 | 68042 | 68190 | 68283 | 68211 | 68403 | 67096 | 64784 | 66761 |
| Diluted weighted average shares | 69605 | 69333 | 69938 | 68283 | 69560 | 69195 | 67568 | 65356 | 67373 |
| Some totals may not add due to rounding | Some totals may not add due to rounding | Some totals may not add due to rounding | Some totals may not add due to rounding | Some totals may not add due to rounding | Some totals may not add due to rounding |  |  |  |  |
| (1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A. | (1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A. | (1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A. | (1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A. | (1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A. | (1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A. | (1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A. | (1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A. | (1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A. | (1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures and the material limitations on the usefulness of these measures, please see Appendix A. |

---

P 20

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  | 6/30/2021 | 9/30/2021 | 12/31/2021 | 3/31/2022 | FY2022 | 6/30/2022 | 9/30/2022 | 12/31/2022 | FY2023 |
| Expenses: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cost of revenue | $34315 | $35079 | $38557 | $39476 | $147427 | $41021 | $42304 | $43287 | $126612 |
| &nbsp;&nbsp;&nbsp;Research and development | 34776 | 35788 | 41870 | 45501 | 157935 | 47661 | 46139 | 43175 | 136975 |
| &nbsp;&nbsp;&nbsp;Sales and marketing | 41979 | 39509 | 46324 | 54951 | 182763 | 51280 | 45949 | 47702 | 144931 |
| &nbsp;&nbsp;&nbsp;General and administrative | 24291 | 23078 | 27639 | 29583 | 104591 | 27144 | 28718 | 36657 | 92519 |
| &nbsp;&nbsp;&nbsp;Gains, losses and other items, net | 1278 | 18 |  | 183 | 1479 | 739 | 13111 | 11743 | 25593 |
| Gross profit: | 84723 | 92211 | 102047 | 102249 | 381230 | 101222 | 104795 | 115328 | 321345 |
| % Gross margin | 71.2% | 72.4% | 72.6% | 72.1% | 72.1% | 71.2% | 71.2% | 72.7% | 71.7% |
| Excluded items: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Purchased intangible asset amortization (cost of revenue) | 4645 | 4612 | 4647 | 4807 | 18711 | 4643 | 4637 | 4209 | 13489 |
| &nbsp;&nbsp;&nbsp;Non-cash stock compensation (cost of revenue) | 790 | 948 | 1168 | 1205 | 4111 | 1163 | 1293 | 1208 | 3664 |
| &nbsp;&nbsp;&nbsp;Non-cash stock compensation (research and development) | 5348 | 7184 | 9264 | 10316 | 32112 | 11656 | 12360 | 10654 | 34670 |
| &nbsp;&nbsp;&nbsp;Non-cash stock compensation (sales and marketing) | 6793 | 6749 | 7329 | 7715 | 28586 | 5884 | 6116 | 5871 | 17871 |
| &nbsp;&nbsp;&nbsp;Non-cash stock compensation (general and administrative) | 5565 | 4340 | 5997 | 6546 | 22448 | 5522 | 7524 | 11891 | 24937 |
| &nbsp;&nbsp;&nbsp;Restructuring and merger charges (gains, losses, and other) | 1278 | 18 |  | 183 | 1479 | 739 | 13111 | 11743 | 25593 |
| &nbsp;&nbsp;&nbsp;Transformation costs (general and administrative) |  |  |  |  |  |  | 1250 | 4112 | 5362 |
| &nbsp;&nbsp;&nbsp;Gain on retained profits interest (other income) | $(30052) | $— | $(183) | $— | (30235) |  |  |  |  |
| Total excluded items | $(5633) | $23851 | $28222 | $30772 | $77212 | $29607 | $46291 | $49688 | $125586 |

---

P 21

------

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) (Continued) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) (Continued) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) (Continued) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) (Continued) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) (Continued) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) (Continued) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) (Continued) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) (Continued) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) (Continued) | RECONCILIATION OF GAAP TO NON-GAAP EXPENSES (1) (Continued) |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  | 6/30/2021 | 9/30/2021 | 12/31/2021 | 3/31/2022 | FY2022 | 6/30/2022 | 9/30/2022 | 12/31/2022 | FY2023 |
| Expenses, excluding items: |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cost of revenue | $28880 | $29519 | $32742 | $33464 | $124605 | $35215 | $36374 | $37870 | $109459 |
| &nbsp;&nbsp;&nbsp;Research and development | 29428 | 28604 | 32606 | 35185 | 125823 | 36005 | 33779 | 32521 | 102305 |
| &nbsp;&nbsp;&nbsp;Sales and marketing | 35186 | 32760 | 38995 | 47236 | 154177 | 45396 | 39833 | 41831 | 127060 |
| &nbsp;&nbsp;&nbsp;General and administrative | 18726 | 18738 | 21642 | 23037 | 82143 | 21622 | 19944 | 20654 | 62220 |
| Gross profit, excluding items: | $90158 | $97771 | $107862 | $108261 | $404052 | $107028 | $110725 | $120745 | $338498 |
| &nbsp;&nbsp;&nbsp;% Gross margin | 75.7% | 76.8% | 76.7% | 76.4% | 76.4% | 75.2% | 75.3% | 76.1% | 75.6% |

---

(1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures, the usefulness of these measures and the material limitations on the usefulness of these measures, please see Appendix A.

P 22

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES | LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES |
| RECONCILIATION OF GAAP TO NON-GAAP OPERATING INCOME(LOSS) GUIDANCE (1) | RECONCILIATION OF GAAP TO NON-GAAP OPERATING INCOME(LOSS) GUIDANCE (1) | RECONCILIATION OF GAAP TO NON-GAAP OPERATING INCOME(LOSS) GUIDANCE (1) | RECONCILIATION OF GAAP TO NON-GAAP OPERATING INCOME(LOSS) GUIDANCE (1) | RECONCILIATION OF GAAP TO NON-GAAP OPERATING INCOME(LOSS) GUIDANCE (1) |
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) |
| (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  | For the quarter ending | For the quarter ending | For the year ending | For the year ending |
|  | March 31, 2023 | March 31, 2023 | March 31, 2023 | March 31, 2023 |
|  | Low | High | Low | High |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GAAP loss from operations | $(26000) | $(23000) | $(105000) | $(102000) |
| Excluded items: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchased intangible asset amortization | 3000 | 3000 | 17000 | 17000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-cash stock compensation | 22000 | 22000 | 103000 | 103000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs | 10000 | 10000 | 36000 | 36000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transformation costs | 4000 | 4000 | 9000 | 9000 |
| Total excluded items | 39000 | 39000 | 165000 | 165000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP income from operations | $13000 | $16000 | $60000 | $63000 |

---

(1) This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. For a detailed explanation of the adjustments made to comparable GAAP measures, the reasons why management uses these measures, the usefulness of these measures and the material limitations on the usefulness of these measures, please see Appendix A.

P 23

------

**APPENDIX A**

LIVERAMP HOLDINGS, INC. AND SUBSIDIARIES

Q2 FISCAL 2023 FINANCIAL RESULTS

EXPLANATION OF NON-GAAP MEASURES AND OTHER KEY METRICS

To supplement our financial results, we use non-GAAP measures which exclude certain acquisition related expenses, non-cash stock compensation and restructuring charges. We believe these measures are helpful in understanding our past performance and our future results. Our non-GAAP financial measures and schedules are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our consolidated GAAP financial statements. Our management regularly uses these non-GAAP financial measures internally to understand, manage and evaluate our business and to make operating decisions. These measures are among the primary factors management uses in planning for and forecasting future periods. Compensation of our executives is also based in part on the performance of our business based on these non-GAAP measures.

Our non-GAAP financial measures, including non-GAAP earnings (loss) per share, income (loss) from operations and adjusted EBITDA reflect adjustments based on the following items, as well as the related income tax effects when applicable:

<u>Purchased intangible asset amortization</u>: We incur amortization of purchased intangibles in connection with our acquisitions. Purchased intangibles include (i) developed technology, (ii) customer and publisher relationships, and (iii) trade names. We expect to amortize for accounting purposes the fair value of the purchased intangibles based on the pattern in which the economic benefits of the intangible assets will be consumed as revenue is generated. Although the intangible assets generate revenue for us, we exclude this item because this expense is non-cash in nature and because we believe the non-GAAP financial measures excluding this item provide meaningful supplemental information regarding our operational performance.

<u>Non-cash stock compensation</u>: Non-cash stock compensation consists of charges for associate restricted stock units, performance shares and stock options in accordance with current GAAP related to stock-based compensation including expense associated with stock-based compensation related to unvested options assumed in connection with our acquisitions. As we apply stock-based compensation standards, we believe that it is useful to investors to understand the impact of the application of these standards to our operational performance. Although stock-based compensation expense is calculated in accordance with current GAAP and constitutes an ongoing and recurring expense, such expense is excluded from non-GAAP results because it is not an expense that typically requires or will require cash settlement by us and because such expense is not used by us to assess the core profitability of our business operations.

<u>Restructuring charges</u>: During the past several years, we have initiated certain restructuring activities in order to align our costs in connection with both our operating plans and our business strategies based on then-current economic conditions. As a result, we recognized costs related to termination benefits for employees whose positions were eliminated, lease and other contract termination charges, and leasehold improvement write offs. These items, reported as gains, losses, and other items, net, are excluded from non-GAAP results because such amounts are not used by us to assess the core profitability of our business operations.

<u>Transformation costs:</u> In previous years, we incurred significant expenses to separate the financial statements of our operating segments, with particular focus on segment-level balance sheets, and to evaluate portfolio priorities. Our criteria for excluding transformation expenses from our non-GAAP measures is as follows: 1) projects are discrete in nature; 2) excluded expenses consist only of third-party consulting fees that we would not incur otherwise; and 3) we do not exclude employee related expenses or other costs associated with the ongoing operations of our business. We substantially completed those projects during the third quarter of fiscal year 2018. Beginning in the fourth quarter of fiscal 2018, and through most of fiscal 2019, we incurred transaction support expenses and system separation costs related to the Company's announced evaluation of strategic options for its Marketing Solutions (AMS) business. In the first and second quarters of fiscal 2021 in response to the potential COVID-19 pandemic impact on our business and again during fiscal 2023 in response to macroeconomic conditions, we incurred significant costs associated with the assessment of strategic and operating plans, including our long-term location

P 24

------

strategy, and assistance in implementing the restructuring activities as a result of this assessment. Our criteria for excluding these costs are the same. We believe excluding these items from our non-GAAP financial measures is useful for investors and provides meaningful supplemental information.

Our non-GAAP financial schedules are:

<u>Non-GAAP EPS, Non-GAAP Income from Operations, and Non-GAAP expenses</u>: Our Non-GAAP earnings per share, Non-GAAP income from operations, and Non-GAAP expenses reflect adjustments as described above, as well as the related tax effects where applicable.

<u>Adjusted EBITDA:</u> Adjusted EBITDA is defined as net income from continuing operations before income taxes, other expenses, depreciation and amortization, and including adjustments as described above. We use Adjusted EBITDA to measure our performance from period to period both at the consolidated level as well as within our operating segments and to compare our results to those of our competitors. We believe that the inclusion of Adjusted EBITDA provides useful supplementary information to and facilitates analysis by investors in evaluating the Company's performance and trends. The presentation of Adjusted EBITDA is not meant to be considered in isolation or as an alternative to net earnings as an indicator of our performance.

<u>Free Cash Flow to Equity</u>: To supplement our statement of cash flows, we use a non-GAAP measure of cash flow to analyze cash flows generated from operations. Free cash flow to equity is defined as operating cash flow less cash used by investing activities (excluding the impact of cash paid in acquisitions), less required payments of debt, and excluding the impact of discontinued operations. Management believes that this measure of cash flow is meaningful since it represents the amount of money available from continuing operations for the Company's discretionary spending after funding all required obligations including scheduled debt payments. The presentation of non-GAAP free cash flow to equity is not meant to be considered in isolation or as an alternative to cash flows from operating activities as a measure of liquidity.

P 25